50242-145 : Perjeta 30 mg/ml Intravenous Injection, Solution, Concentrate
| NDC: | 50242-145 |
| Labeler: | Genentech, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Perjeta |
| Dosage Form: | Intravenous Injection, Solution, Concentrate |
| Application #: | BLA125409 |
| Rev. Date: |
NDC Package Codes:
- 50242-145-01: 1 VIAL, SINGLE‑USE IN 1 CARTON (50242‑145‑01) > 14 ML IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Pertuzumab
Dosage Strength:
- 30 mg/mL
Pharmaceutical Classes:
- HER2 Receptor Antagonist [EPC]
- HER2/Neu/cerbB2 Antagonists [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 50242-143Next: 50242-150 >
Related Discussions:
Side Effects of Perjeta?
Has anyone experienced cold like symptoms for an extended length of time after their last Perjeta infusion? I have had a... 2 replies
Has anyone experienced cold like symptoms for an extended length of time after their last Perjeta infusion? I have had a... 2 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.